Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)
Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%
Viatris price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Viatris's price to sales ratio was 0.9× on Jan 31, 2025, against 0.9× a year earlier. Over the last 5 years it ranged from 0.0× to 1.0×, with a median of 0.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 0.9× | −0.1 |
| 2024 | Dec 31, 2024 | 1.0× | +0.1 |
| 2023 | Dec 29, 2023 | 0.8× | +0.0 |
| 2022 | Dec 30, 2022 | 0.8× | −0.1 |
| 2021 | Dec 31, 2021 | 0.9× | +0.9 |
| 2020 | Dec 31, 2020 | 0.0× | −0.9 |
| 2019 | Dec 31, 2019 | 0.9× | – |
See a number that looks wrong?